Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C

Thomas Imperiale, Areen T. Said, Oscar Cummings, Lawrence J. Born

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

OBJECTIVE: A value of ≥1 for the ratio of aspartate aminotransferase to alanine aminotransferase (the AST/ALT ratio or AAR) has been shown to have a positive predictive value of 100% for the diagnosis of cirrhosis in patients with chronic hepatitis C. If validated on separate cohorts, an AAR ≥ 1 might obviate the need for liver biopsy in some patients with hepatitis C. METHODS: We attempted to validate the AAR by abstracting demographic and clinical data from a database of consecutive patients with hepatitis C who had a liver biopsy between 1993 and 1998. We used definitions, methods of data collection, and analyses comparable to those of the published study. A hepatopathologist blindly reviewed 49 liver biopsies for histological grade and stage. RESULTS: The current cohort of 177 patients and the previous cohort of 139 patients were comparable in mean age (42.3 vs 43.8 yr), percentage of men (63 vs 67), percentage with an AAR ≥1 (20 vs17), and Child-Pugh distribution, but differed in substantial use of ethanol (11% vs 3.6%; p = 0.01) and in the prevalence of cirrhosis (23% vs 34%, p = 0.06). Respective sensitivities of the AAR were 56% and 53%. An AAR ≥1 had a positive predictive value of 64% (95% confidence interval 48-78%) for the current cohort. Thirteen of 36 patients (36%) with an AAR ≥1 were incorrectly identified as having cirrhosis. Of these 13 patients, 6 had a normal AST and ALT, 5 had a minimally elevated AST or ALT, and 1 had advanced fibrosis without cirrhosis. CONCLUSIONS: These results suggest that an AAR ≥1 may not be as useful for predicting cirrhosis in chronic hepatitis C as previously thought, and emphasizes the need for validation of clinical decision aids on independent patient cohorts. (C) 2000 by Am. Coll. of Gastroenterology.

Original languageEnglish
Pages (from-to)2328-2332
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume95
Issue number9
DOIs
StatePublished - 2000

Fingerprint

Decision Support Techniques
Chronic Hepatitis C
Fibrosis
Hepatitis C
Biopsy
Liver
Gastroenterology
Aspartate Aminotransferases
Alanine Transaminase
Ethanol
Demography
Databases
Confidence Intervals

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Need for validation of clinical decision aids : Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. / Imperiale, Thomas; Said, Areen T.; Cummings, Oscar; Born, Lawrence J.

In: American Journal of Gastroenterology, Vol. 95, No. 9, 2000, p. 2328-2332.

Research output: Contribution to journalArticle

@article{79e5c8c7869b4e21aa5532dac58a7abf,
title = "Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C",
abstract = "OBJECTIVE: A value of ≥1 for the ratio of aspartate aminotransferase to alanine aminotransferase (the AST/ALT ratio or AAR) has been shown to have a positive predictive value of 100{\%} for the diagnosis of cirrhosis in patients with chronic hepatitis C. If validated on separate cohorts, an AAR ≥ 1 might obviate the need for liver biopsy in some patients with hepatitis C. METHODS: We attempted to validate the AAR by abstracting demographic and clinical data from a database of consecutive patients with hepatitis C who had a liver biopsy between 1993 and 1998. We used definitions, methods of data collection, and analyses comparable to those of the published study. A hepatopathologist blindly reviewed 49 liver biopsies for histological grade and stage. RESULTS: The current cohort of 177 patients and the previous cohort of 139 patients were comparable in mean age (42.3 vs 43.8 yr), percentage of men (63 vs 67), percentage with an AAR ≥1 (20 vs17), and Child-Pugh distribution, but differed in substantial use of ethanol (11{\%} vs 3.6{\%}; p = 0.01) and in the prevalence of cirrhosis (23{\%} vs 34{\%}, p = 0.06). Respective sensitivities of the AAR were 56{\%} and 53{\%}. An AAR ≥1 had a positive predictive value of 64{\%} (95{\%} confidence interval 48-78{\%}) for the current cohort. Thirteen of 36 patients (36{\%}) with an AAR ≥1 were incorrectly identified as having cirrhosis. Of these 13 patients, 6 had a normal AST and ALT, 5 had a minimally elevated AST or ALT, and 1 had advanced fibrosis without cirrhosis. CONCLUSIONS: These results suggest that an AAR ≥1 may not be as useful for predicting cirrhosis in chronic hepatitis C as previously thought, and emphasizes the need for validation of clinical decision aids on independent patient cohorts. (C) 2000 by Am. Coll. of Gastroenterology.",
author = "Thomas Imperiale and Said, {Areen T.} and Oscar Cummings and Born, {Lawrence J.}",
year = "2000",
doi = "10.1016/S0002-9270(00)01114-X",
language = "English",
volume = "95",
pages = "2328--2332",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Need for validation of clinical decision aids

T2 - Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C

AU - Imperiale, Thomas

AU - Said, Areen T.

AU - Cummings, Oscar

AU - Born, Lawrence J.

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: A value of ≥1 for the ratio of aspartate aminotransferase to alanine aminotransferase (the AST/ALT ratio or AAR) has been shown to have a positive predictive value of 100% for the diagnosis of cirrhosis in patients with chronic hepatitis C. If validated on separate cohorts, an AAR ≥ 1 might obviate the need for liver biopsy in some patients with hepatitis C. METHODS: We attempted to validate the AAR by abstracting demographic and clinical data from a database of consecutive patients with hepatitis C who had a liver biopsy between 1993 and 1998. We used definitions, methods of data collection, and analyses comparable to those of the published study. A hepatopathologist blindly reviewed 49 liver biopsies for histological grade and stage. RESULTS: The current cohort of 177 patients and the previous cohort of 139 patients were comparable in mean age (42.3 vs 43.8 yr), percentage of men (63 vs 67), percentage with an AAR ≥1 (20 vs17), and Child-Pugh distribution, but differed in substantial use of ethanol (11% vs 3.6%; p = 0.01) and in the prevalence of cirrhosis (23% vs 34%, p = 0.06). Respective sensitivities of the AAR were 56% and 53%. An AAR ≥1 had a positive predictive value of 64% (95% confidence interval 48-78%) for the current cohort. Thirteen of 36 patients (36%) with an AAR ≥1 were incorrectly identified as having cirrhosis. Of these 13 patients, 6 had a normal AST and ALT, 5 had a minimally elevated AST or ALT, and 1 had advanced fibrosis without cirrhosis. CONCLUSIONS: These results suggest that an AAR ≥1 may not be as useful for predicting cirrhosis in chronic hepatitis C as previously thought, and emphasizes the need for validation of clinical decision aids on independent patient cohorts. (C) 2000 by Am. Coll. of Gastroenterology.

AB - OBJECTIVE: A value of ≥1 for the ratio of aspartate aminotransferase to alanine aminotransferase (the AST/ALT ratio or AAR) has been shown to have a positive predictive value of 100% for the diagnosis of cirrhosis in patients with chronic hepatitis C. If validated on separate cohorts, an AAR ≥ 1 might obviate the need for liver biopsy in some patients with hepatitis C. METHODS: We attempted to validate the AAR by abstracting demographic and clinical data from a database of consecutive patients with hepatitis C who had a liver biopsy between 1993 and 1998. We used definitions, methods of data collection, and analyses comparable to those of the published study. A hepatopathologist blindly reviewed 49 liver biopsies for histological grade and stage. RESULTS: The current cohort of 177 patients and the previous cohort of 139 patients were comparable in mean age (42.3 vs 43.8 yr), percentage of men (63 vs 67), percentage with an AAR ≥1 (20 vs17), and Child-Pugh distribution, but differed in substantial use of ethanol (11% vs 3.6%; p = 0.01) and in the prevalence of cirrhosis (23% vs 34%, p = 0.06). Respective sensitivities of the AAR were 56% and 53%. An AAR ≥1 had a positive predictive value of 64% (95% confidence interval 48-78%) for the current cohort. Thirteen of 36 patients (36%) with an AAR ≥1 were incorrectly identified as having cirrhosis. Of these 13 patients, 6 had a normal AST and ALT, 5 had a minimally elevated AST or ALT, and 1 had advanced fibrosis without cirrhosis. CONCLUSIONS: These results suggest that an AAR ≥1 may not be as useful for predicting cirrhosis in chronic hepatitis C as previously thought, and emphasizes the need for validation of clinical decision aids on independent patient cohorts. (C) 2000 by Am. Coll. of Gastroenterology.

UR - http://www.scopus.com/inward/record.url?scp=0033834092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033834092&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(00)01114-X

DO - 10.1016/S0002-9270(00)01114-X

M3 - Article

C2 - 11007237

AN - SCOPUS:0033834092

VL - 95

SP - 2328

EP - 2332

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -